LL-37
인체 카테리시딘(Human cathelicidin) — 광범위 항균 펩타이드
개요
LL-37은 인체에서 유일한 카텔리시딘 항균 펩타이드로, 세균, 바이러스, 진균에 대한 광범위 방어 기능을 제공합니다.
Key Information
Mechanism
미생물 막을 파괴하고 면역 체계를 조절합니다. 직접적인 항균 + 면역조절 효과가 있습니다.
Benefits
- 광범위 항균 작용
- 항바이오필름 활성
- 면역 조절
- 상처 치유 지원
Side Effects
- 치료량 미만 용량에서의 내성 발생 가능성
- 고농도에서의 자극
Contraindications
- None established
Evidence Summary
연구에 따르면 박테리아 및 바이오필름에 대한 효능과 면역 조절 효과가 있는 것으로 나타났습니다.
Research
연구에 따르면 세균 감염 및 바이오필름에 대한 효능이 있으며, 만성 감염에서 면역 조절제로서의 효과가 있는 것으로 나타났습니다.
View ResearchSafety
일반적으로 내약성이 양호함. 아치료용량 투여 시 내성 발생 가능성이 있음.
Frequently Asked Questions About LL-37
What is LL-37?
LL-37 is a research peptide also known as Cathelicidin; hCAP-18. 인체 카테리시딘(Human cathelicidin) — 광범위 항균 펩타이드 It is studied for its potential therapeutic applications and is available from various research chemical vendors.
How does LL-37 work?
미생물 막을 파괴하고 면역 체계를 조절합니다. 직접적인 항균 + 면역조절 효과가 있습니다.
What is the recommended dosage for LL-37?
The commonly studied dosage range for LL-37 is Varies by application. Dosage protocols vary based on research objectives. Always consult published studies and start with conservative amounts. LL-37 should only be used in controlled research settings.
Where can I buy LL-37?
PepsReview indexes LL-37 pricing from multiple vendors. Check the Vendors tab above for a price comparison table showing cost per milligram, purity, COA status, and stock availability. Vendor reviews from real users are available on each vendor's profile page.
Is LL-37 legal?
US regulatory status: Research only. The legal status of LL-37 varies by jurisdiction. In most countries, it is sold as a research chemical, not for human consumption. Always verify the legal status in your country before purchasing.
What are the side effects of LL-37?
Reported side effects include: 치료량 미만 용량에서의 내성 발생 가능성, 고농도에서의 자극. Always review safety data and published studies before use.
Key Research Papers on LL-37
The following peer-reviewed studies and clinical trials are indexed in our research library for LL-37. Each paper links to a detailed summary with key findings, study design, and publication metadata.
- LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity — Pharmacol Rep, 2016 (200 citations)
- Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37 — Adv Exp Med Biol, 2019 (140 citations)
- LL-37 Triggers Antimicrobial Activity in Human Platelets — Int J Mol Sci, 2023 (60 citations)
- The LL-37 domain: A clue to cathelicidin immunomodulatory response? — Peptides, 2023 (60 citations)
- Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications — Int J Mol Sci, 2025 (20 citations)
No vendor prices yet
We don't have pricing data for this peptide yet.
Write a Review
Rating Breakdown
Based on 2 리뷰.
리뷰
LL-37 cleared a chronic bacterial infection that antibiotics couldn't touch. The broad-spectrum antimicrobial activity is impressive. Anti-biofilm properties make it effective against resistant bacteria. Wound healing also accelerated.
LL-37 is a remarkable immune weapon. Fought off a stubborn sinus infection in days. The antimicrobial and antiviral defense is broad-spectrum. Be careful with dosing - too much can cause inflammation.